Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127599471 | 12759947 | 1 | I | 20160627 | 20160906 | 20160919 | 20160919 | EXP | FR-PFIZER INC-2016423721 | PFIZER | 69.00 | YR | F | Y | 0.00000 | 20160919 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127599471 | 12759947 | 1 | PS | Dalacine | CLINDAMYCIN HYDROCHLORIDE | 1 | Oral | 300 MG, 6X/DAY | Y | 50162 | 300 | MG | CAPSULE, HARD | ||||||
| 127599471 | 12759947 | 2 | SS | Amlor | AMLODIPINE BESYLATE | 1 | Oral | UNK | Y | 19787 | CAPSULE, HARD | ||||||||
| 127599471 | 12759947 | 3 | SS | CORDARONE | AMIODARONE HYDROCHLORIDE | 1 | Oral | UNK | Y | 18972 | TABLET | ||||||||
| 127599471 | 12759947 | 4 | SS | RIMACTAN /00146901/ | RIFAMPIN | 1 | Oral | 300 MG, 2X/DAY | 4800 | MG | Y | 0 | 300 | MG | CAPSULE | BID | |||
| 127599471 | 12759947 | 5 | SS | CALCIPARINE | HEPARIN CALCIUM | 1 | Subcutaneous | 0.4 ML, 1X/DAY | .667 | ML | Y | 0 | .4 | ML | INJECTION | QD | |||
| 127599471 | 12759947 | 6 | SS | DOLIPRANEORO | ACETAMINOPHEN | 1 | Oral | 500 MG, 2X/DAY | 8000 | MG | D | 0 | 500 | MG | BID | ||||
| 127599471 | 12759947 | 7 | SS | FUMAFER | FERROUS FUMARATE | 1 | Oral | 66 MG, 2X/DAY | 3432 | MG | Y | 0 | 66 | MG | FILM-COATED TABLET | BID | |||
| 127599471 | 12759947 | 8 | SS | GAVISCON REGULAR STRENGTH | ALUMINUM HYDROXIDEMAGNESIUM TRISILICATE | 1 | Oral | 1 DF, 3X/DAY | 27 | DF | D | 0 | 1 | DF | TID | ||||
| 127599471 | 12759947 | 9 | SS | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | 0.4 ML, DAILY | 19 | ML | D | 0 | .4 | ML | |||||
| 127599471 | 12759947 | 10 | SS | VANCOMYCIN SANDOZ | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 2 G, DAILY | D | 0 | 2 | G | POWDER FOR SOLUTION FOR INFUSION | ||||||
| 127599471 | 12759947 | 11 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG, DAILY | 0 | 75 | MG | ||||||||
| 127599471 | 12759947 | 12 | SS | LASILIX /00032601/ | FUROSEMIDE | 1 | Oral | 40 MG, DAILY | Y | 0 | 40 | MG | TABLET | ||||||
| 127599471 | 12759947 | 13 | SS | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 4 G, 3X/DAY | 240 | G | D | 0 | 4 | G | TID | ||||
| 127599471 | 12759947 | 14 | SS | DIFFU K | POTASSIUM CHLORIDE | 1 | Oral | 600 MG, 6X/DAY | D | 0 | 600 | MG | |||||||
| 127599471 | 12759947 | 15 | SS | AMBROXOL EG | AMBROXOL | 1 | Oral | 1 DF, 3X/DAY | 12 | DF | D | 0 | 1 | DF | ORAL SOLUTION | TID | |||
| 127599471 | 12759947 | 16 | SS | TIORFAN | RACECADOTRIL | 1 | Oral | 100 MG, 3X/DAY | 900 | MG | Y | 0 | 100 | MG | CAPSULE | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127599471 | 12759947 | 1 | Sternitis |
| 127599471 | 12759947 | 3 | Atrial fibrillation |
| 127599471 | 12759947 | 4 | Sternitis |
| 127599471 | 12759947 | 5 | Thrombosis prophylaxis |
| 127599471 | 12759947 | 7 | Anaemia |
| 127599471 | 12759947 | 9 | Thrombosis prophylaxis |
| 127599471 | 12759947 | 10 | Sternitis |
| 127599471 | 12759947 | 12 | Cardiac failure |
| 127599471 | 12759947 | 13 | Sternitis |
| 127599471 | 12759947 | 14 | Hypokalaemia |
| 127599471 | 12759947 | 15 | Bronchial disorder |
| 127599471 | 12759947 | 16 | Diarrhoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127599471 | 12759947 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127599471 | 12759947 | Acute kidney injury | |
| 127599471 | 12759947 | Drug reaction with eosinophilia and systemic symptoms | |
| 127599471 | 12759947 | Nephropathy toxic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127599471 | 12759947 | 1 | 20160620 | 20160628 | 0 | |
| 127599471 | 12759947 | 2 | 20160625 | 20160708 | 0 | |
| 127599471 | 12759947 | 3 | 20160602 | 20160701 | 0 | |
| 127599471 | 12759947 | 4 | 20160620 | 20160628 | 0 | |
| 127599471 | 12759947 | 5 | 20160626 | 20160628 | 0 | |
| 127599471 | 12759947 | 6 | 20160615 | 20160622 | 0 | |
| 127599471 | 12759947 | 7 | 20160602 | 20160708 | 0 | |
| 127599471 | 12759947 | 8 | 20160615 | 20160623 | 0 | |
| 127599471 | 12759947 | 9 | 20160509 | 20160625 | 0 | |
| 127599471 | 12759947 | 10 | 20160601 | 20160620 | 0 | |
| 127599471 | 12759947 | 11 | 20160602 | 20160809 | 0 | |
| 127599471 | 12759947 | 12 | 20160510 | 20160626 | 0 | |
| 127599471 | 12759947 | 13 | 20160601 | 20160620 | 0 | |
| 127599471 | 12759947 | 14 | 20160611 | 20160622 | 0 | |
| 127599471 | 12759947 | 15 | 20160611 | 20160614 | 0 | |
| 127599471 | 12759947 | 16 | 20160625 | 20160708 | 0 |